Hydrogen Therapy Shows Promise for Chronic Kidney Disease Treatment

Authors
Journal
Biomedicine & Pharmacotherapy
Year
DOI
10.1016/j.biopha.2024.116802
Study Type
clinical
Peer Reviewed
Yes
Country
Taiwan
Health Condition
Chronic Kidney Disease
Body System
Renal

TL;DR

Scientists found that a simple gas called molecular hydrogen might help protect kidneys from damage by getting rid of harmful molecules that build up and cause problems in people with chronic kidney disease. While lab tests look really promising, doctors still need to do more real-world testing with actual patients to prove it actually works.

Key Finding

Molecular hydrogen selectively neutralizes harmful free radicals while preserving beneficial reactive oxygen species and activates key antioxidant defense pathways, suggesting potential therapeutic value for chronic kidney disease.

Summary

This review examines how molecular hydrogen (H2) might help treat chronic kidney disease, a condition where the kidneys gradually lose function. The authors explain that kidney damage in this disease is driven by oxidative stress—an imbalance of harmful molecules called free radicals. Molecular hydrogen appears to neutralize these harmful molecules while preserving beneficial ones, and it activates the body's natural antioxidant defense systems. However, the authors note that while laboratory studies show promise, actual clinical trials in humans are still limited.

Practical Takeaway

While laboratory evidence suggests molecular hydrogen may help reduce oxidative stress in kidney disease, this is a review of existing research rather than a new clinical study. The authors emphasize that human clinical trials are still limited, so it remains unclear whether hydrogen water would actually benefit people with chronic kidney disease. Anyone with kidney disease should consult their doctor before trying hydrogen water or any new treatment.

Abstract (excerpt)

Oxidative stress plays a key role in chronic kidney disease (CKD) development and progression, inducing kidney cell damage, inflammation, and fibrosis. However, effective therapeutic interventions to slow down CKD advancement are currently lacking. The multifaceted pharmacological effects…

Read the full abstract via DOI